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Abstract
Background: Postpartum haemorrhage (PPH) is the leading cause of maternal deaths, the world over. The aim of
this study was to determine laboratory parameters that could serve as risk factors for primary PPH.
Methods: This comparative cohort study involved 350 pregnant women at term who were recruited consecutively
from the Komfo Anokye Teaching Hospital, Kumasi, Ghana. PPH was defined as a measured blood loss ≥ 500 ml or
enough to cause haemodynamic shock. Basic demographic data was gathered and blood was collected for laboratory
assays before delivery. Univariate and multivariate logistic regression models were used to identify variables that were
significantly associated with primary PPH.
Results: Of the total recruited study participants (350), five declined to participate and 74 went through caesarean
section, episiotomy or instrumental deliveries and were excluded. Of the remaining (271) study participants who went
through spontaneous vaginal delivery, fifty five (55) were diagnosed with primary PPH (Group 1) and the remaining
216 were those who did not have PPH (Group 2). Demographic characteristics did not differ between the two groups
(P > 0.05). Univariate analysis showed that AST (P = 0.043), urea (P < 0.001), creatinine (P = 0.002), urea-to-creatinine ratio
(P = 0.014) and the proportion of abnormal peripheral blood smear (P < 0.001) was higher among women in Group 1
compared to those in Group 2. Women in Group 1 had a significantly lower haemoglobin concentration (10.7 g/dL)
compared to those in Group 2 (12.1g/dL). Upon multivariate analysis, an abnormal peripheral blood smear
(AOR = 2.9672), Hb, (AOR = 0.5791), moderate to severe anaemia (Hb <10 g/dL) (AOR = 3.1385), Urea (AOR =
3.6435) and intra-renal azotaemia (AOR = 0.1893) remained significant.
Conclusion: Many laboratory parameters are associated with primary PPH but only a few are independent
risk factors. A total clinical work-up including laboratory evaluation of the independent blood variables
identified in this study will help a great deal to identify individuals at high risk for PPH.
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Background
Each year, about 289,000 women worldwide, die from
various complications of pregnancy and childbirth and
developing countries account for 99 % (286,000) of
this rate [1]. In 2013, Ghana recorded a maternal
mortality rate of 380 per 100,000 live births [2].
Among the various causes of maternal mortality,
postpartum haemorrhage (PPH) has historically been
the single most important [3].
Primary PPH is defined as a loss of 500 ml or more of
blood (or any amount that causes haemodynamic com-
promise) during and after childbirth, within the first
twenty-four hours [4]. The condition presents with sev-
eral consequences, which could transform a healthy
pregnant woman in labour to a critically ill patient [5],
and efforts to save both mother and baby may pose
serious challenges to health workers [6].
Although the burden of primary PPH is severe, only
few studies in the developing world, have examined
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laboratory risk factors associated with primary PPH. Risk
factors associated with primary PPH, as reported by
other studies include non-white ethnicity [7], older age
[8], history of PPH [9], history of blood disorders [7],
nulliparity [10], low parity [11], grand multiparity [12],
high blood pressure [13], antepartum haemorrhage [14]
and multiple pregnancies [8].
However, many of these factors have a low predictive
value [13]. Reports show that prediction of PPH with the
current antenatal screenings is poor and about 60 % of
cases have no identifiable risk [15, 16]. Other studies
have shown that in women with three or more risk fac-
tors, predictive ability is as low as 10 % [17], with Tsu’s
long-standing 1993 study reporting a prediction rate of
below 7 % [18]. Furthermore, most reports on risk fac-
tors for PPH were conducted in the developed world,
where conditions, facilities, expertise and even the ex-
perience of patients may vary from that in the develop-
ing world. This is supported by reports on the role of
intrapartum factors - of which the above factors play a
vital role, in the development of primary PPH [7, 9, 12,
13, 19, 20]. With the huge burden associated with pri-
mary PPH there is a need for continued examination
of risk factors to provide better opportunities for pre-
vention, intervention or active management in the
early stages.
The main objective of this study was to determine
laboratory parameters that could serve as risk factors for
primary PPH. We hypothesized that various antepartum
laboratory parameters will be associated with primary
PPH and may be of value in the clinical management of
pregnant women during labour.
Methods
Study design/Site
This was a comparative cohort study with a consecutive
sampling technique, carried out from April to October
2012. Three hundred and fifty (350) women who had
been admitted to the labour ward of the Department of
Obstetrics and Gynaecology, Komfo Anokye Teaching
Hospital (KATH), Kumasi, Ghana, were recruited for the
study. This was done under the supervision of qualified
midwives and Obstetrician/Gynaecologists.
Eligibility
To qualify for recruitment, the pregnant women had to
be on admission at the labour ward, with singleton preg-
nancy and should have consented to participate in the
study. Women of all parity were included.
Women who underwent planned or emergency caesar-
ean section, episiotomy and instrumental deliveries were
excluded. Patients who bled after initial blood volumes
had been estimated were also excluded. Women with
pregnancy induced hypertension or pre-eclampsia,
chronic metabolic diseases of which they were being
treated or managed (e.g. diabetes mellitus, chronic kid-
ney disease), hepatitis, HIV and tuberculosis were ex-
cluded. Inclusion was ascertained through review of
patient folders in consultation with attending physicians.
Participants
Three hundred and fifty (350) pregnant women who had
been admitted to the labour ward of the Department of
Obstetrics and Gynaecology for delivery were recruited
as a start cohort. All recruited participants were followed
up until delivery and an attending Obstetrician/Gynae-
cologist did an appropriate assessment of clinical status/
diagnosis.
Five of the eligible recruits declined to participate in
the study whereas 74 other patients underwent caesar-
ean section, episiotomy or instrumental delivery or were
lost to follow up. Of the 271 women who had normal
vaginal delivery, 55 developed primary PPH (Group 1)
and 216 did not develop primary PPH – normal vaginal
delivery (Group 2).
Sample and data collection
Prior to delivery, about 9 ml venous blood sample was
collected from each participant into sodium citrate tubes
for coagulation studies (Prothrombin Time - PT and
activated Partial Thromboplastin Time - aPTT),
serum separator tubes for biochemical assays (Total
protein- TP, Albumin - ALB, Globulins-GLOB, Ala-
nine Aminotransferase - ALT, Aspartate Aminotrans-
ferase - AST, urea -URE and creatinine - CRE) and
ethylenediaminetetraacetic acid tubes (EDTA) tubes
for haematological assays (Full Blood Count - FBC,
Erythrocyte Sedimentation Rate - ESR, Glucose-6-
phosphate Dehydrogenase - G6PD, sickling, blood
group and peripheral blood smear).
Haematological assays were performed on fresh
anticoagulated blood using an automated analyser
(Mindray BC 3000 Plus, Shenzhen, China). Serum
separator and sodium citrated samples were centri-
fuged and aliquots of plasma or serum were stored
at −80°C until assayed. Biochemical assays were per-
formed using an automated analyser (Selectra Pro S,
Vital Scientific NV, Netherlands). Coagulation param-
eters were assayed using a semi-automated analyser
(Coatron M4 TECO Medical Instruments, Germany).
All other parameters were gathered from the patient
records.
Measurement of blood loss
Deliveries were done on a dry disposable “linen saver” as
suggested in a similar study [21]. The amniotic fluid was
allowed to drain away and blood was allowed to collect
into a graduated receptacle placed below the delivery
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bed, after which a qualified Midwife measured the
amount of blood loss. Diagnosis of primary PPH (by an
attending physician-Obstetrician/Gynaecologist) was
based on vaginal delivery with a measured blood loss of
500 ml or more, up to one hour post-delivery. Vaginal
delivery with a measured blood loss of less than 500 ml
but enough to cause signs of haemodynamic comprom-
ise (e.g. weakness, syncope, decreased level of conscious-
ness, dizziness, chest discomfort, dyspnoea, hypotension
diaphoresis and pulmonary congestion) also constituted
primary PPH [4, 5, 8, 22].
Outcome criteria
All laboratory results were classified into various cat-
egories based on reference ranges with respect to preg-
nancy to accommodate the physiological changes [23].
In the peripheral blood smear, any feature consist-
ent with the presence of abnormal number, shape,
size and age of cells constituted an abnormal periph-
eral blood smear.
Classification of anaemia was as per the recommenda-
tions of the World Health Organization [24]. Azotaemia
was classified as pre-renal when urea: creatinine ratio
was > 100, post-renal when ratio was from 40–100 and
intra-renal when ratio was < 40.
Statistics
Data was entered into a Microsoft Excel spreadsheet and
statistical analysis was done using the R-console (The R
foundation for statistical computing, http://www.R-pro
ject.org). We reported categorical variables as frequen-
cies and proportions and compared them with Chi-
square and Fisher’s exact test as appropriate. We
reported continuous variables as mean (SD) or median
(IQR) based on data distribution (normal or skewed
respectively) and compared them using Wilcoxon-
Mann–Whitney (Rank sum) test and Independent sam-
ples t-test for skewed and normally distributed data
respectively. Multivariate logistic regression analysis
was done to identify independent risk factors associ-
ated with primary PPH. Independent risk factors were
identified using an automatic selection process (MODEL-
STEP), which removes non-significant variables and con-
founders in a stepwise backward selection process, based
on a likelihood ratio static. An Akaike’s Information
Criterion (AIC) is constantly generated and the last
MODELSTEP with the smallest AIC was selected as the
best-fit model. Due to the low numbers of some blood
types observed, this variable was categorised into “Blood
type O” and “non-O blood types”.
Ethical Consent
The study was approved by the Committee on Human
Research Publication and Ethics (CHRPE) of the Kwame
Nkrumah University of Science and Technology (KNUST)/
School of Medical Sciences (SMS) as well as the Research
and Development unit of the KATH. The objective of the
study was explained to all participants and written in-
formed consent was obtained before recruitment.
Results
Of the total number of participants approached (350),
five declined to participate and a further 74 were
excluded from data analysis and presentation due to se-
lection criteria used in the present study. Of the
remaining 271 study participants who went through
spontaneous vaginal delivery, fifty five (55) were diag-
nosed with primary PPH (Group 1) where as two hun-
dred and sixteen (216) did not present with any such
complication (Group 2).
The mean age of participants was 27.7 ± 5.7 years and
Groups 1 and 2 did not differ based on age, BMI, parity,
gravidity, history of antepartum bleeding, induced and
spontaneous abortions, transfusions, contraception, fi-
broids and surgery (P > 0.05).
Table 1 shows a list of biochemical and coagulation
parameters of the study population. AST (P = 0.043),
urea (P < 0.001), creatinine (P = 0.002) and Urea-to-
creatinine ratio (P = 0.014) levels were higher amongst
women in Group 1 than in Group 2.
Women in Group 1 had a significantly lower Hb (10.7
g/dL) compared to 12.1 g/dL in Group 2 (P < 0.001). A
larger proportion of Group 1 participants had moderate/
severe anaemia in addition to an abnormal peripheral
blood smear, than in Group 2 (P < 0.001 each). Total
WBC, NEUT, MONO and ESR levels were higher
amongst women in Group 1 compared to Group 2 (P <
0.05). Laboratory-confirmed presence of malaria para-
sitaemia was low (6.3 %) in the total population.
[Tables 2 and 3]
Upon multivariate analysis, five variables remained
significant. An abnormal peripheral blood smear was as-
sociated with the development of primary PPH (AOR =
2.9672). For every unit increase in Hb, the odds of devel-
oping primary PPH decreased 0.5791 times (95 % CI =
0.4585 to 0.7314) and women with moderate to severe
anaemia (Hb <10 g/dL) were three times more likely to
develop primary PPH than women with no or mild an-
aemia. For every unit increase in serum urea, the odds
of primary PPH increased 3.6435 times. Intra-renal
azotaemia was associated with a less likelihood of de-
veloping primary PPH (AOR = 0.1893, 95 % CI =
0.0602 to 0.5955) compared to pre-renal or post-renal
azotaemia. [Table 4]
Discussion
We hypothesized that various antepartum laboratory
parameters will be associated with primary PPH and will
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Table 1 Biochemical and coagulation parameters of study participants
Parameters All women (n = 271) Group 1 (n = 55) Group 2 (n = 216) P value
AST median (IQR) 17 (13.5,21) 18 (15,22.5) 16 (13,20) 0.043
ALT median (IQR) 9 (6,11) 8 (6.5,11) 9 (6,11) 0.48
TP median (IQR) 68 (63,73) 66 (59.5,74) 68 (63,73) 0.315
ALB median (IQR) 36 (34,38) 35 (31.5,38) 37 (35,39) 0.001
GLOB median (IQR) 30 (28,34) 31 (27.5,36) 30 (28,34) 0.889
URE median (IQR) 1.8 (1.5,2.4) 2.5 (1.8,3.2) 1.8 (1.5,2.3) <0.001
CRE median (IQR) 66 (52.5,78.5) 72 (61,90.5) 61.5 (51,75.2) 0.002
URE: CRE
Median (IQR) 28 (22,38) 31 (24,45) 27 (21,36.8) 0.014
Intra-renal azotaemia n (%) 217 (80.7) 35 (63.6) 182 (85) <0.001
Normal n (%) 50 (18.6) 18 (32.7) 32 (15)
Pre-renal azotaemia n (%) 2 (0.7) 2 (3.6) 0 (0)
PT median (IQR) 13 (12,15) 14 (13,16) 13 (12,15) 0.096
INR median (IQR) 1.1 (1,1.3) 1.2 (1.1,1.4) 1.1 (1,1.3) 0.096
aPTT median (IQR) 28 (24,36) 31 (24,38) 28 (24.8,33.5) 0.576
Data are presented as n (%) or median (IQR). All P values less than 0.05 were considered significant. Group 1: Women with primary PPH. Group 2: Women without
primary PPH. IQR: Inter-quartile range. n: Number. AST: Aspartate Transaminase. ALT: Alanine Transaminases. TP: Total Protein. ALB: Albumin. GLOB: Globulins.
URE: Urea. CRE: Creatinine. PT: Prothrombin Time. aPTT: Activated Partial Thromboplastin Time. INR: International Normalised Ratio
Table 2 Haematological parameters of study participants
Parameters All women (n = 271) Group 1 (n = 55) Group 2 (n = 216) P value
Hb (g/dL) median (IQR) 11.9 (10.9,12.8) 10.7 (8.5,12.3) 12.1 (11.3,13) <0.001
ANAEMIA n (%)
Mod-Sev 36 (13.3) 22 (40) 14 (6.5) <0.001
Mild 37 (13.7) 9 (16.4) 28 (13)
Normal 198 (73.1) 24 (43.6) 174 (80.6)
G6PD n (%)
Full Defect 12 (4.4) 0 (0) 12 (5.6) 0.169
No Defect 257 (94.8) 55 (100) 202 (93.5)
Partial Defect 2 (0.7) 0 (0) 2 (0.9)
SICKLING n (%)
Negative 235 (86.7) 47 (85.5) 188 (87) 0.931
Positive 36 (13.3) 8 (14.5) 28 (13)
BLOOD GROUP n (%)
Non-O groups 130 (47.9) 22 (40) 108 (50) 0.227
Group O 141 (52.1) 33 (60) 108 (50)
HCT median (IQR) 36.1 (32.9,38.5) 32.1 (25.2,36.8) 36.5 (33.6,38.5) <0.001
MCV median (IQR) 84.8 (80.5,88.6) 85.9 (81.6,88.2) 84 (80.1,88.7) 0.426
MCH median (IQR) 28.1 (26.9,29.7) 29 (27.4,30.1) 28.1 (26.8,29.6) 0.151
MCHC median (IQR) 33.2 (32.6,34.3) 33.4 (32.8,34.3) 33.2 (32.6,34.3) 0.248
PLT mean (SD) 205.8 (66.8) 210 (69.3) 204.7 (66.2) 0.597
Data are presented as n (%) or median (IQR) or mean (SD). All P values less than 0.05 were considered significant. Group 1: Women with primary PPH. Group 2:
Women without primary PPH. IQR: Inter-quartile range. n: Number. Mod: Moderate. Sev: Severe. Hb: Haemoglobin. G6PD: Glucose-6-Phosphate Dehydrogenase.
HCT: Haematocrit. MCV: Mean Cell Volume. MCH: Mean cell haemoglobin. MCHC: Mean Corpuscular Haemoglobin Concentration. PLT: Platelets
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have the ability for identification of high-risk groups.
The results of our study confirm this hypothesis but
only few of the parameters included in the present
study showed independent association. A number of
factors showed an association with primary PPH;
AST, urea, creatinine, urea-to-creatinine ratio, haemo-
globin concentration, WBC, ESR and the state of a
peripheral blood smear (normal or abnormal). Multi-
variate analysis showed that increasing urea and urea-
to-creatinine ratio, decreasing haemoglobin concentration
(<10 g/dL) and an abnormal peripheral blood smear
were independently associated with a higher likeli-
hood of developing primary PPH.
Biochemical parameters and primary PPH
AST and ALB levels, although differed significantly be-
tween the two groups, were within normal limits of
pregnancy [23]. This is similar to a study where there
was significant changes in ALT but not in other liver en-
zymes [25]. Higher levels of AST than ALT could be
accounted for from other sources of the enzyme, the
heart, skeletal muscles, kidney, brain and red cells [26].
The exclusion of participants with liver infection and
other chronic liver diseases could be a contributing fac-
tor for the observation of normal liver function markers
amongst the study participants.
Urea and creatinine levels were higher amongst Group
1 (women with primary PPH) than in Group 2. Creatin-
ine is expected to decline in pregnancy [23, 27], hence
mild elevations during pregnancy may signify mild renal
insufficiency, as opposed to that in non-pregnant
women. We however did not determine the estimated
glomerular filtration rate (eGFR) of participants, there-
fore this suggestion is not conclusive. Upon multivariate
analysis, Urea and urea-to-creatinine ratio remained
significant associations of primary PPH. It has been sug-
gested that excess urea can cause an upregulation of
endothelial nitric oxide through shunting of L-arginine
to form guanidinosuccinic acid [28]. Consequently, this
Table 3 Haematological parameters of study participants
Parameters All women (n = 271) Group 1 (n = 55) Group 2 (n = 216) P value
WBC median (IQR)
Total 9.4 (7.4,12.9) 10.2 (8.8,15) 9.4 (7.1,12.5) 0.023
NEUT 7.3 (5.1,11) 8.6 (6,12.9) 7 (4.8,9.8) 0.004
LYMPH 1.5 (1.2,2) 1.6 (1.2,1.9) 1.5 (1.2,2) 0.831
MONO 0.7 (0.6,0.9) 0.8 (0.5,1.2) 0.7 (0.6,0.9) 0.017
EO 0 (0,0.1) 0 (0,0.1) 0 (0,0.1) 0.116
BASO 0 (0,0) 0 (0,0) 0 (0,0) 0.119
ESR (mm/hr) median (IQR) 56 (39.5,76) 70 (48,96) 55 (37,75) 0.018
MALARIA PARASITAEMIA n (%)
Negative 254 (93.7) 51 (92.7) 203 (94) 0.756
Positive 17 (6.3) 4 (7.3) 13 (6)
PERIPHERAL BLOOD SMEAR n (%)
Abnormal 99 (36.5) 39 (70.9) 60 (27.8) <0.001
Normal 172 (63.5) 16 (29.1) 156 (72.2)
Data are presented as n (%) or median (IQR) or mean (SD). All P values less than 0.05 were considered significant. Group 1: Women with primary PPH. Group 2:
Women without primary PPH. IQR: Inter-quartile range. N: Number. WBC; White Blood Cell. NEUT: neutrophils. LYMPH: Lymphocyte. MONO: Monocytes. EO: Eosinophil.
BASO: Basophil. ESR: Erythrocyte Sedimentation Rate
Table 4 Multivariate analysis for independent factors associated
with primary PPH
Parameter Adj OR 95 % CI P value
Peripheral blood smear
*Normal
Abnormal 2.9672 1.3323 to 6.6083 0.0078
Hb 0.5791 0.4585 to 0.7314 <0.0001
Anaemia
*Normal
Mod-severe 3.1385 1.2099 to 8.1412 0.0187
URE: CRE
* Normal
Intrarenal azotaemia 0.1893 0.0602 to 0.5955 0.0044
UREA 3.6435 2.0968 to 6.3311 <0.0001
CRE: Creatinine. URE: Urea. OR: Odds ratio. Adj: Adjusted. CI: Confidence
Interval. P values less <0.05 were considered significant. * Reference variable
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causes reduced endothelial adhesion of platelets due to
impaired Von-Willibrand Factor (VWF) binding to
platelets, therefore higher bleeding tendencies [28].
Coagulopathy and primary PPH
Measures of coagulation, PT and aPTT did not differ
between the two groups and hence showed no signifi-
cant association. It is expected that bleeding tendencies
will correlate with abnormalities in coagulation markers.
Although the current study could not demonstrate this
the finding is still in line with findings that coagulation
abnormalities contribute only about 1 % of the causes of
PPH [29], hence our observation. It is important how-
ever, to note that coagulation abnormalities cannot be
ruled out. Suggestions are that a hypercoagulable state
results in the second and third trimesters due to an
increased synthesis and activity of coagulation factors −
fibrinogen, coagulation factors (F) VII, VIII, IX, X, XII,
and VWF − and results in a shortened PT and aPTT
[30]. This could be a contributing factor to our observa-
tion of a pseudo-normal PT and aPTT. Hence coagu-
lation abnormalities may have been present but
masked by physiological changes, and may be appar-
ent only after pregnancy.
Haematological parameters and primary PPH
We found that increasing haemoglobin concentrations
were associated with a less likelihood of primary PPH
and that women with [Hb] < 10 (moderate-severe an-
aemia) were more likely to develop primary PPH.
Anaemia is responsible for 17–46 % of cases of maternal
deaths when combined with obstetric haemorrhage [22].
In addition, complications of PPH, pre-term delivery and
foetal growth restriction are more frequent in anaemic
women [31]. In a similar study, women in Zimbabwe
with an [Hb] of less than 12 g/dL were 2.2 times more
likely to develop PPH than non-PPH controls [18].
Researchers in Tanzania reported that [Hb] of < 9 g/dL
was strongly associated with bleeding in the immediate
postpartum period [12]. In contrast to our findings, two
previous studies reported no association between an-
aemia and PPH in Nigeria [32] and no difference in risk
of postpartum haemorrhage between severe and moder-
ate anaemia in Ghana [33]. These studies however relied
on visual estimation, a technique known to underesti-
mate blood loss [5, 34].
It has been hypothesized that severe anaemia may
weaken uterine muscles or lower resistance to infectious
diseases thus leading to PPH [35, 36]. Furthermore,
decreased uterine blood flow or low uterine muscle
strength may contribute to inefficient uterine contrac-
tions and contribute to blood loss, potentially mediated
by iron-deficiency anaemia [37, 38]. The findings of this
current study have demonstrated that the severity of
anaemia places a woman at a greater risk of experiencing
PPH. It also confirms the hypothesis that severe anaemia
may impair the tolerance of women to the effects of
PPH due to their inability to endure excessive blood
losses [39, 40].
The association of low haemoglobin concentrations
and thus anaemia with primary PPH is consistent with
our observation that an abnormal blood film was associ-
ated with a higher risk of primary PPH. It is noteworthy
that the morphological appearance and number of red
cells are largely affected by the haemoglobin concentra-
tion and anaemia. Furthermore, other conditions that
may affect platelet function and numbers leading to an
abnormal peripheral blood smear may stimulate bleeding
thus leading to PPH.
Recommendations and impact on health delivery system
Currently in Ghana, the routine antenatal laboratory
tests and screening include some but not all the parame-
ters and variables identified in the present study. While
we have made progress, the current interventions are in-
adequate. The practicality of carrying out the extra tests
proposed in the present study, including cost, capacity
of the facility and the laboratory, as well as cost implica-
tions to the patient and the facility should be evaluated
appropriately by the relevant authority. Accordingly, a
review of antenatal policies to cater for such additional
proposed tests may be warranted.
A total clinical work-up including laboratory evalu-
ation of the independent blood variables identified in
this study could help in identifying individuals at high
risk or otherwise for PPH. The will contribute to preven-
tion, intervention or ensuring preparations for active
management in the early stages.
In settings where there is lack of skilled personnel,
a more preventive approach to primary PPH is rec-
ommended; indicators identified in the present study
could be used to identify and refer high-risk individ-
uals to better-resourced facilities to prevent maternal
and neonatal death in the event of the occurrence of
primary PPH.
Conclusions
Many laboratory parameters are associated with primary
PPH, However, only a few serve as independent risk
factors; increasing urea and urea-to-creatinine ratio,
decreasing haemoglobin concentration (<10 g/dL) and
an abnormal peripheral blood smear were independently
associated with a higher likelihood of developing
primary PPH.
Limitations
There is a limitation on the generalization of the study
findings due to the consecutive sampling technique and
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the relatively smaller sample size used. Further studies
using a larger sample pool in matched case–control
studies are warranted. Furthermore, a representation
of haemoglobin levels and the extent of blood loss in
each group would better buttress the relationship be-
tween Hb and the extent of blood loss required for
primary PPH development. However given the lack of
availability of such data in Ghana, findings from this
study however remain relevant and add to evidence
on the subject matter.
Abbreviations
ALB: Albumin; ALT: Alanine Aminotransferase; AMSTL: Active Management
of the Third Stage of Labour; aPTT: Activated Partial Thromboplastin Time;
AST: Aspartate Aminotransferase; CRE: Creatinine; EDTA: ethylene-diamine-
tetra-acetic acid; ESR: Erythrocyte Sedimentation Rate; FBC: Full Blood
Count; G6PD: Glucose-6-phosphate Dehydrogenase; GLOB: Globulins;
KATH: Komfo Anokye Teaching Hospital; MDG: Millennium Development
Goals; PPH: Postpartum haemorrhage; PT: Prothrombin time; TP: Total
Protein; URE: urea; VWF: Von-Willibrand Factor.
Competing interests
The authors hereby declare that there are no competing interests regarding
this publication.
Authors' contributions
WKBAO was involved in conception of the idea, study design, interpretation
of data, revision and final approval of the manuscript. DNMO was involved
in conception of the idea, study design, data collection, compilation and
analysis of data and drafting of the manuscript. CAT was involved in
conception of the idea, study design recruitment and allocation of
participants during data collection, revision and final approval of the
manuscript. OOA was involved in data collection, interpretation of data,
literature search and drafting of manuscript. All authors read and
approved the final manuscript.
Acknowledgements
Our gratitude goes to the nurses and staff at the labour ward, ward A2,
KATH and to Margaret Rosa-Puckey and Asamoah Kyei, for their contribution
in patient recruitment. We appreciate Mr. David Sambien and all staff
of the malaria research laboratory, KATH. Also to Dr. Richard Kobina
Dadzie Ephraim of UCC, Dr. Christian Obirikorang of SMS/KNUST and
James Osei Yeboah of UHAS, Ho, Ghana.
Author details
1Department of Molecular Medicine, School of Medical Sciences (SMS),
Kwame Nkrumah University of Science and Technology (KNUST), Kumasi,
Ghana. 2Department of Obstetrics and Gynaecology, Komfo Anokye
Teaching Hospital (KATH)/SMS, KNUST, Kumasi, Ghana.
Received: 15 February 2014 Accepted: 13 January 2016
References
1. WHO: Trends in maternal mortality: 1990 to 2013. In: Estimates by WHO,
UNICEF, UNFPA, The World Bank and the United Nations Population
Division. Geneva, Switzerland: World health organization; 2014.
2. Maternal mortality ratio (modeled estimate, per 100,000 live births)
[http://data.worldbank.org/indicator/SH.STA.MMRT]
3. Rath WH. Postpartum hemorrhage–update on problems of definitions and
diagnosis. Acta Obstet Gynecol Scand. 2011;90(5):421–8.
4. Naz H, Sarwar I, Fawad A, Nisa AU. Maternal morbidity and mortality due to
primary PPH: experience at Ayub Teaching Hospital Abbottabad. J Ayub
Med College Abbottabad. 2008;20(2):59–65.
5. Maternity-Prevention, Early Recognition and Management of Postpartum
Haemorrhage (PPH). In. North Sydney: Department of Health, New South
Wales; 2010: 16.
6. El-Refaey H, Rodeck C. Post-partum haemorrhage: definitions, medical and
surgical management. A time for change. Br Med Bull. 2003;67:205–17.
7. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC.
Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South
Med J. 2005;98(4):419–22.
8. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors
of severe obstetric haemorrhage. BJOG. 2008;115(10):1265–72.
9. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors,
and causes. Clin Obstet Gynecol. 2010;53(1):147–56.
10. Magann EF, Doherty DA, Briery CM, Niederhauser A, Chauhan SP, Morrison
JC. Obstetric characteristics for a prolonged third stage of labor and risk for
postpartum hemorrhage. Gynecol Obstet Invest. 2008;65(3):201–5.
11. Combs CA, Murphy EL, Laros Jr RK. Factors associated with postpartum
hemorrhage with vaginal birth. Obstet Gynecol. 1991;77(1):69–76.
12. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE.
Association between anaemia during pregnancy and blood loss at and after
delivery among women with vaginal births in Pemba Island, Zanzibar,
Tanzania. J Health Popul Nutr. 2008;26(2):232–40.
13. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and
outcome of pregnancies complicated with early postpartum hemorrhage:
a population-based study. J Matern Fetal Neonatal Med. 2005;18(3):149–54.
14. Marchant S, Alexander J, Thomas P, Garcia J, Brocklehurst P, Keene J.
Risk factors for hospital admission related to excessive and/or prolonged
postpartum vaginal blood loss after the first 24 h following childbirth.
Paediatr Perinat Epidemiol. 2006;20(5):392–402.
15. Ramanathan G, Arulkumaran S. Postpartum hemorrhage. J Obstet Gynaecol
Can. 2006;28(11):967–73.
16. Maughan KL, Heim SW, Galazka SS. Preventing postpartum hemorrhage:
managing the third stage of labor. Am Fam Physician. 2006;73(6):1025–8.
17. Prata N, Hamza S, Bell S, Karasek D, Vahidnia F, Holston M. Inability to
predict postpartum hemorrhage: insights from Egyptian intervention data.
BMC Pregnancy Childbirth. 2011;11:97.
18. Tsu VD. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J
Obstet Gynaecol. 1993;100(4):327–33.
19. Geller SE, Goudar SS, Adams MG, Naik VA, Patel A, Bellad MB, et al. Factors
associated with acute postpartum hemorrhage in low-risk women
delivering in rural India. Int J Gynaecol Obstet. 2008;101(1):94–9.
20. Lertbunnaphong T, Leetheeragul J, Thitadilok W. Risk factors of primary
postpartum hemorrhage in Siriraj Hospital. Siriraj Med J. 2010;62:5.
unpaginated.
21. Gulmezoglu AM, Hofmeyr GJ. Prevention and treatment of postpartum
haemorrhage. In: MacLean AB, Neilson J, editors. Maternal Morbidity and
Mortality. London: RCOGPress; 2002. p. 434.
22. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum
haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol.
2008;22(6):999–1012.
23. Tran HA. Biochemical tests in pregnancy. Australian Prescriber. 2005;28(4):99.
24. DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG.
Preventing and controlling iron deficiency anemia through primary health
care. A guide for Health administrators and program managers. Geneva,
Switzerland: World Health Organization; 1989. p. 26.
25. Puri M, Patra S, Singh P, Malhotra N, Trivedi SS, Sharma S, et al. Factors
influencing occurrence of postpartum haemorrhage in pregnant women
with hepatitis E infection and deranged coagulation profile. Obstetric Med.
2011;4:108–12.
26. Cheesbrough M. District Laboratory Practice in Tropical Countries. vol. 2nd
ed. New York: Cambridge University Press; 2006. p. 329–33.
27. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory
studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–31.
28. Collins PW, Thachil J, Toh C-H. Acquired Coagulation Disorders. In: Hoffbrand
AV, Catovsky D, Tuddenham EGD, Green AR, editors. Postgraduate
Haematology. 6th ed. Oxford, U.K: Blackwell Publishing; 2011. p. 839–59.
29. Anderson J, Etches D, Smith D: Postpartum haemorrhage. In Damos J R,
Eisinger S H, eds. Kansas: American Academy of Family Physicians; 2000.
30. Ahonen J, Stefanovic V, Lassila R. Management of post-partum
haemorrhage. Acta Anaesthesiol Scand. 2010;54(10):1164–78.
31. Fareh OI, Rizk DE, Thomas L, Berg B. Obstetric impact of anaemia in pregnant
women in United Arab Emirates. J Obstet Gynaecol. 2005;25(5):440–4.
32. Selo-Ojeme DO, Okonofua FE. Risk factors for primary postpartum
haemorrhage. A case control study. Arch Gynecol Obstet. 1997;259(4):
179–87.
Owiredu et al. BMC Pregnancy and Childbirth  (2016) 16:17 Page 7 of 8
33. Geelhoed D, Agadzi F, Visser L, Ablordeppey E, Asare K, O'Rourke P, et al.
Maternal and fetal outcome after severe anemia in pregnancy in rural
Ghana. Acta Obstet Gynecol Scand. 2006;85(1):49–55.
34. Turpin CA, Osakunor DNM, Owiredu WKBA. Accuracy of Blood Loss
Determination after Vaginal Delivery: Visual Estimation versus Calibrated
Measurement. BJMMR. 2015;6(11):1121–7.
35. Rush D. Nutrition and maternal mortality in the developing world. Am J Clin
Nutr. 2000;72(1 Suppl):212S–40S.
36. Bergstrom S. Infection-related morbidities in the mother, fetus and neonate.
J Nutr. 2003;133(5 Suppl 2):1656S–60S.
37. Brotanek V, Hendricks CH, Yoshida T. Changes in uterine blood flow during
uterine contractions. Am J Obstet Gynecol. 1969;103(8):1108–16.
38. Ulmer HU, Goepel E. Anemia, ferritin and preterm labor. J Perinat Med.
1988;16(5–6):459–65.
39. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J
Clin Nutr. 2000;71(5 Suppl):1280S–4S.
40. Alauddin M. Maternal mortality in rural Bangladesh: the Tangail District.
Stud Fam Plann. 1986;17(1):13–21.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Owiredu et al. BMC Pregnancy and Childbirth  (2016) 16:17 Page 8 of 8
